GRACE

The GRACE integrated solution aims to transform the healthcare ecosystem by providing essential knowledge and innovative public-private partnership for (1) reorganizing healthcare services (2) with embedded innovative technologies and tools, helping identifying and overcoming barriers and gaps that are now hindering CVD management, ensuring a seamless continuum of care and optimized care pathways. Our vision is that introducing effective health technology and interventions is economically, societally and environmentally sustainable if and only accompanied by a substantial healthcare service re-organization. Accordingly, GRACE will focus on an end-to-end clinical pathway CVD, considering an holistic view of the patient and optimizing healthcare services leveraging on advanced technological solutions. GRACE intervention will be multifold aiming at: (1) guiding strategic policies, (2) drive market innovation, and (3) foster effective healthcare delivery practices in CVD, generating value for patients, healthcare workers and system. GRACE’s will enable early and personalized interventions, fostering coordination of multidiscipline healthcare teams, triggering more intense and person-specific management using innovative technologies, AI and digital solutions for early detection of red flags, promoting patient empowerment, while comprehensively containing CVD risk factors and burden.

In the GRACE project, CERTH participates as a project partner with a key role in risk management and quality assurance. CERTH leads Task T1.3 “Risk management & quality assurance” throughout the project, supporting continuous quality assessment, identification and mitigation of potential risks, coordination of technical and quality-related activities, and review of project deliverables. CERTH also participates in the activities related to the dissemination and exploitation of GRACE’s results.

Consortium

UNIVERSITA CAMPUS BIO MEDICO DI ROMA (UCBM)
MEDTRONIC IBERICA SA (MDT-IB)
ACTIVE AGEING ASSOCIATION (ACTIVAGE)
PHILIPS MEDICAL SYSTEMS NEDERLAND BV (PMSN)
PHILIPS MEDICAL SYSTEMS TECHNOLOGIES LTD (PMST)
SAMSUNG ELECTRONICS (UK) LIMITED (SAMSUNG)
DEDALUS ITALIA S.P.A. (DEDALUS)
MEDTRONIC FRANCE (MDT-FR)
ASTRAZENECA FARMACEUTICA SPAIN, S.A (AZ)
BRIDG OU (BRD)
PREDICTBY RESEARCH AND CONSULTING S.L. (PBY)
HAPPY MONDAYS COMMUNICATION SL (HMC)
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (CERTH)
FUNDACION PARA LA INVESTIGACION BIOSANITARIA DE ANDALUCIA ORIENTAL-ALEJANDRO OTERO (FIBAO)
SERVICIO MADRILENO DE SALUD (SERMAS)
OUTCOMES’10 SL (O10)
CENTRE HOSPITALIER UNIVERSITAIRE DE RENNES (CHU)
CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.) (CNIC)
UNIVERSITATSKLINIKUM BONN (UKB)
UNIVERSITAIR MEDISCH CENTRUM UTRECHT (UMCU)
Wavy Assistant B.V. (WAVY)
FONDAZIONE POLICLINICO UNIVERSITARIO CAMPUS BIO MEDICO (FPUCBM)
HUMAN FACTOR & INNOVATION SRL START-UP (HFI)
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS (FPG)
INSTITUT CATALA DE LA SALUT (ICS-HUB)